Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.78%98.56M | 10.11%98.46M | 8.18%94.61M | 6.76%362.28M | 7.06%93.1M | 6.12%92.3M | 5.23%89.42M | 8.74%87.46M | 5.67%339.34M | 10.20%86.96M |
| Operating revenue | 6.78%98.56M | 10.11%98.46M | 8.18%94.61M | 6.76%362.28M | 7.06%93.1M | 6.12%92.3M | 5.23%89.42M | 8.74%87.46M | 5.67%339.34M | 10.20%86.96M |
| Cost of revenue | 6.09%74.38M | 11.28%76.35M | 2.80%71.08M | 2.41%279.25M | 3.25%71.38M | -0.16%70.11M | 2.49%68.61M | 4.18%69.14M | 12.26%272.67M | 11.69%69.14M |
| Gross profit | 8.98%24.18M | 6.25%22.11M | 28.47%23.53M | 24.54%83.03M | 21.85%21.72M | 32.44%22.19M | 15.41%20.81M | 30.26%18.32M | -14.80%66.67M | 4.77%17.82M |
| Operating expense | -16.24%27M | -8.94%26.78M | -26.61%25.56M | -8.41%119.36M | -32.64%22.89M | -4.89%32.24M | -5.34%29.41M | 11.14%34.84M | 19.07%130.32M | 13.21%33.97M |
| Selling and administrative expenses | -19.25%21.53M | -9.73%21.61M | -28.71%20.23M | -4.70%96.45M | -34.05%17.47M | -0.11%26.67M | -0.71%23.93M | 18.84%28.38M | 19.38%101.21M | 13.23%26.49M |
| -Selling and marketing expense | -21.73%11.88M | -18.99%11.95M | -40.80%10.99M | -12.42%59.38M | -41.93%10.89M | -12.23%15.18M | -7.95%14.75M | 17.97%18.57M | 25.71%67.81M | 28.87%18.75M |
| -General and administrative expense | -15.98%9.65M | 5.14%9.66M | -5.87%9.24M | 10.96%37.07M | -14.94%6.58M | 22.19%11.49M | 13.66%9.19M | 20.53%9.82M | 8.30%33.41M | -12.52%7.73M |
| Research and development costs | 1.45%4.68M | -3.94%4.34M | -12.14%4.41M | -3.07%18.63M | -10.57%4.47M | -4.21%4.62M | -1.29%4.52M | 4.17%5.02M | 35.45%19.22M | 25.86%5M |
| Depreciation amortization depletion | -17.80%785K | -12.93%828K | -35.65%924K | -56.67%4.29M | -62.05%943K | -59.86%955K | -60.04%951K | -45.73%1.44M | -5.63%9.89M | -5.98%2.49M |
| -Depreciation and amortization | -17.80%785K | -12.93%828K | -35.65%924K | -56.67%4.29M | -62.05%943K | -59.86%955K | -60.04%951K | -45.73%1.44M | -5.63%9.89M | -5.98%2.49M |
| Operating profit | 71.95%-2.82M | 45.71%-4.67M | 87.69%-2.03M | 42.92%-36.33M | 92.76%-1.17M | 41.38%-10.05M | 34.04%-8.6M | 4.42%-16.52M | -104.01%-63.65M | -24.25%-16.15M |
| Net non-operating interest income (expenses) | -6.16%-13.9M | -8.51%-13.62M | -14.60%-13.61M | -22.75%-51.28M | -8.67%-13.75M | -21.94%-13.1M | -19.54%-12.55M | -50.75%-11.88M | -188.95%-41.77M | -114.39%-12.65M |
| Non-operating interest income | -25.56%527K | -31.95%460K | -48.50%515K | -29.59%3.16M | --774K | --708K | 531.78%676K | --1M | 3,297.73%4.49M | ---- |
| Non-operating interest expense | 4.53%14.43M | 6.44%14.08M | 9.70%14.13M | 17.68%54.43M | -15.25%14.52M | 28.53%13.8M | 24.71%13.23M | 63.44%12.88M | 217.08%46.26M | 184.04%17.14M |
| Other net income (expenses) | -198.09%-3.84M | 30.54%4.92M | -27.36%2.68M | -706.29%-14.27M | -723.21%-25.64M | -8.50%3.92M | 136.01%3.77M | -15.61%3.69M | -86.83%2.35M | -7.53%4.11M |
| Special income (charges) | -197.04%-3.74M | 45.96%4.9M | -24.30%2.74M | -724.82%-14.7M | -728.58%-25.53M | -10.64%3.85M | 132.31%3.36M | -17.14%3.62M | -86.96%2.35M | -9.69%4.06M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --10.95M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | --10.72M | ---- | ---- | --17.73M | --17.73M | --0 | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14.68M | --0 |
| -Gain on sale of property,plant,equipment | 81.29%6.99M | 45.96%4.9M | -24.30%2.74M | -17.94%13.98M | -22.53%3.15M | -10.64%3.85M | -21.73%3.36M | -17.14%3.62M | -5.61%17.03M | -9.69%4.06M |
| Other non-operating income (expenses) | ---- | ---- | ---- | --436K | ---106K | --66K | --409K | --67K | ---- | ---- |
| Income before tax | -6.97%-20.56M | 23.08%-13.37M | 47.52%-12.97M | 1.16%-101.87M | -64.26%-40.56M | 18.53%-19.22M | 48.86%-17.38M | -18.84%-24.71M | -270.92%-103.07M | -70.84%-24.69M |
| Income tax | -20.10%2.46M | 85.66%2.27M | 22.10%2.17M | 216.19%7.99M | 245.74%1.92M | 473.97%3.07M | 140.33%1.22M | 203.74%1.77M | -3,067.28%-6.87M | -30.69%-1.32M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -3.24%-23.02M | 15.95%-15.64M | 42.86%-15.13M | -14.20%-109.86M | -81.72%-42.48M | 2.09%-22.3M | 39.93%-18.6M | -38.78%-26.48M | -248.91%-96.2M | -73.85%-23.37M |
| Net income continuous operations | -3.24%-23.02M | 15.95%-15.64M | 42.86%-15.13M | -14.20%-109.86M | -81.72%-42.48M | 2.09%-22.3M | 39.93%-18.6M | -38.78%-26.48M | -248.91%-96.2M | -73.85%-23.37M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -3.24%-23.02M | 15.95%-15.64M | 42.86%-15.13M | -14.20%-109.86M | -81.72%-42.48M | 2.09%-22.3M | 39.93%-18.6M | -38.78%-26.48M | -248.91%-96.2M | -73.85%-23.37M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -3.24%-23.02M | 15.95%-15.64M | 42.86%-15.13M | -14.20%-109.86M | -81.72%-42.48M | 2.09%-22.3M | 39.93%-18.6M | -38.78%-26.48M | -248.91%-96.2M | -73.85%-23.37M |
| Diluted earnings per share | -2.46%-2.08 | 17.06%-1.41 | 43.39%-1.37 | -13.22%-10.02 | -80.84%-3.87 | 2.87%-2.03 | 40.56%-1.7 | -36.72%-2.42 | -245.70%-8.85 | -71.20%-2.14 |
| Basic earnings per share | -2.46%-2.08 | 17.06%-1.41 | 43.39%-1.37 | -13.22%-10.02 | -80.84%-3.87 | 2.87%-2.03 | 40.56%-1.7 | -36.72%-2.42 | -245.70%-8.85 | -71.20%-2.14 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.